Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Women with cardiovascular disease have increased risk of osteoporotic fracture.

Chen JS, Hogan C, Lyubomirsky G, Sambrook PN.

Calcif Tissue Int. 2011 Jan;88(1):9-15. doi: 10.1007/s00223-010-9431-7. Epub 2010 Nov 4.

PMID:
21046091
2.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
3.

Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.

Eisman J, Clapham S, Kehoe L; Australian BoneCare Study.

J Bone Miner Res. 2004 Dec;19(12):1969-75. Epub 2004 Sep 13.

4.

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95.

PMID:
15645517
5.

High osteoporotic fracture risk and CVD risk co-exist in postmenopausal women.

Makovey J, Macara M, Chen JS, Hayward CS, March L, Sambrook PN.

Bone. 2013 Jan;52(1):120-5. doi: 10.1016/j.bone.2012.09.025. Epub 2012 Sep 27.

PMID:
23023015
6.

Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah.

Wengreen HJ, Munger RG, West NA, Cutler DR, Corcoran CD, Zhang J, Sassano NE.

J Bone Miner Res. 2004 Apr;19(4):537-45. Epub 2004 Feb 9.

7.

Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group.

Ensrud KE, Duong T, Cauley JA, Heaney RP, Wolf RL, Harris E, Cummings SR.

Ann Intern Med. 2000 Mar 7;132(5):345-53.

PMID:
10691584
8.

Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.

Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.

J Endocrinol Invest. 2005;28(10 Suppl):80-4. Review.

PMID:
16550729
9.

Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.

Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr.

J Am Geriatr Soc. 2004 Sep;52(9):1543-8.

PMID:
15341559
10.

Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.

[No authors listed]

Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.

PMID:
20061894
11.

[Therapeutic concepts in the treatment of postmenopausal osteoporosis].

Leidig-Bruckner G, Ziegler R.

Ther Umsch. 1994 Nov;51(11):737-47. German.

PMID:
7839332
12.

Fracture risk in early postmenopausal women assessed using FRAX.

Trémollieres F, Cochet T, Cohade C, Pouillès JM, Ribot C.

Joint Bone Spine. 2010 Jul;77(4):345-8. doi: 10.1016/j.jbspin.2010.04.012. Epub 2010 Jun 4.

PMID:
20605507
13.

Preventing osteoporotic fractures in older people.

McCloskey E.

Practitioner. 2011 Jan;255(1736):19-22, 2-3.

PMID:
21370710
14.

Identification of osteopenic women at high risk of fracture: the OFELY study.

Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD.

J Bone Miner Res. 2005 Oct;20(10):1813-9. Epub 2005 Jun 20.

15.

Osteoporosis: new hope for the future.

Masi L, Bilezikian JP.

Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54. Review.

PMID:
9309458
16.

Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study.

Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z.

Am J Clin Nutr. 2009 Jan;89(1):323-30. doi: 10.3945/ajcn.2008.26451. Epub 2008 Dec 3.

17.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
18.

Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women.

Marci CD, Anderson WB, Viechnicki MB, Greenspan SL.

Calcif Tissue Int. 2000 Feb;66(2):113-8. Erratum in: Calcif Tissue Int 2000 Nov;67(5):425.

PMID:
10652958
19.
20.

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

Kanis JA, Johansson H, Oden A, McCloskey EV.

Bone. 2009 Jun;44(6):1049-54. doi: 10.1016/j.bone.2009.02.014. Epub 2009 Feb 28.

PMID:
19254788

Supplemental Content

Support Center